Want to create an interactive transcript for this episode?
Podcast: CME
Episode: ns-MRAs and Biomarkers: The NT-proBNP Connection
Description:
Guest: Muthiah Vaduganathan, MD, MPH
Guest: Orly Vardeny, MD
Discover the transformative potential of nonsteroidal mineralocorticoid receptor antagonists (ns-MRAs) in optimizing care for patients with the Cardiovascular-Kidney-Metabolic syndrome. Emerging data presented at EASD, HFSA, ASN and AHA, highlight their ability to improve cardiorenal outcomes in the spectrum of the Cardiovascular-Kidney-Metabolic syndrome. By integrating ns-MRAs into individualized treatment plans, healthcare professionals can offer their patients advanced care backed by cutting-edge research.